Elos Medtech AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SEK 251.2 million compared to SEK 231.5 million a year ago. Net income was SEK 21.6 million compared to SEK 21.9 million a year ago. Basic earnings per share from continuing operations was SEK 2.68 compared to SEK 2.71 a year ago.
For the nine months, sales was SEK 788.2 million compared to SEK 659.1 million a year ago. Net income was SEK 54.5 million compared to SEK 74.6 million a year ago. Basic earnings per share from continuing operations was SEK 6.75 compared to SEK 9.24 a year ago.